Literature DB >> 16473763

Angiogenesis: the VE-cadherin switch.

Yann Wallez1, Isabelle Vilgrain, Philippe Huber.   

Abstract

Because angiogenesis is a key step in a number of pathologic processes, including tumor growth and atherosclerosis, many research studies have investigated the regulatory signals active at various stages of vascular invasion. The differential activities of the endothelial junction protein vascular endothelial (VE)-cadherin reflect the versatile behavior of endothelial cells between vascular quiescence and angiogenesis. VE-cadherin function and signaling are deeply modified in proliferating cells, and this conversion is accompanied by phosphorylation of the protein on tyrosine residues and enhanced transcription of its gene. Recent advances in the complex interplay between protein tyrosine kinases and phosphatases regulating VE-cadherin phosphorylation and function are discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16473763     DOI: 10.1016/j.tcm.2005.11.008

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  43 in total

1.  Anti-apoptosis effects of vascular endothelial cadherin in experimental corneal neovascularization.

Authors:  Gao-Qin Liu; Hong-Ya Wu; Jing Xu; Meng-Jiao Wang; Pei-Rong Lu; Xue-Guang Zhang
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

2.  Role of vascular and lymphatic endothelial cells in hantavirus pulmonary syndrome suggests targeted therapeutic approaches.

Authors:  Erich R Mackow; Elena E Gorbunova; Nadine A Dalrymple; Irina N Gavrilovskaya
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

3.  Hantavirus interferon regulation and virulence determinants.

Authors:  Erich R Mackow; Nadine A Dalrymple; Velasco Cimica; Valery Matthys; Elena Gorbunova; Irina Gavrilovskaya
Journal:  Virus Res       Date:  2014-01-08       Impact factor: 3.303

4.  Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells.

Authors:  Yoshimasa Nakamura; Nikolay Patrushev; Hyoe Inomata; Dolly Mehta; Norifumi Urao; Ha Won Kim; Masooma Razvi; Vidisha Kini; Kalyankar Mahadev; Barry J Goldstein; Ronald McKinney; Tohru Fukai; Masuko Ushio-Fukai
Journal:  Circ Res       Date:  2008-05-01       Impact factor: 17.367

5.  TGF-beta1 induces rearrangement of FLK-1-VE-cadherin-beta-catenin complex at the adherens junction through VEGF-mediated signaling.

Authors:  Brandoch D Cook; Giovanni Ferrari; Giuseppe Pintucci; Paolo Mignatti
Journal:  J Cell Biochem       Date:  2008-12-15       Impact factor: 4.429

6.  The detection of vascular endothelial growth factor in serum of patients with hemorrhagic fever with renal syndrome.

Authors:  Man Li; Yuqiang Ji; Yanying Dong; Yan Zhou; Huixun Ren; Ming Xie
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

7.  Contribution of annexin 2 to the architecture of mature endothelial adherens junctions.

Authors:  Stéphanie Heyraud; Michel Jaquinod; Claire Durmort; Emilie Dambroise; Evelyne Concord; Jean Patrick Schaal; Philippe Huber; Danielle Gulino-Debrac
Journal:  Mol Cell Biol       Date:  2007-12-26       Impact factor: 4.272

8.  Suppression of retinal neovascularization with an antagonist to vascular endothelial cadherin.

Authors:  Deepti Navaratna; Joann Maestas; Paul G McGuire; Arup Das
Journal:  Arch Ophthalmol       Date:  2008-08

9.  The role of VE-cadherin in osteosarcoma cells.

Authors:  Li-Zhi Zhang; Jiong Mei; Zhi-Kang Qian; Xuan-Song Cai; Yao Jiang; Wei-Da Huang
Journal:  Pathol Oncol Res       Date:  2009-09-17       Impact factor: 3.201

10.  Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis.

Authors:  Jo Nadine Fleming; Howard M Shulman; Richard A Nash; Pamela Y Johnson; Thomas N Wight; Allen Gown; Stephen M Schwartz
Journal:  PLoS One       Date:  2009-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.